Hereditary Sensory Neuropathy Type 1 (HSN1)Symptoms, Doctors, Treatments, Advances & More
Hereditary Sensory Neuropathy Type 1 (HSN1) Overview
Learn About Hereditary Sensory Neuropathy Type 1 (HSN1)
- Hereditary sensory neuropathy type 1
- HSAN 1
- HSN1
- Hereditary sensory and autonomic neuropathy type 1
- Neuropathy hereditary sensory and autonomic type 1
- Neuropathy hereditary sensory radicular, autosomal dominant
Thorsten Hornemann practices practicing medicine in Zurich, Switzerland. Mr. Hornemann is rated as an Elite expert by MediFind in the treatment of Hereditary Sensory Neuropathy Type 1 (HSN1). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Hereditary Sensory Neuropathy Type 1 (HSN1), Hereditary Sensory and Autonomic Neuropathy Type 2, Hajdu-Cheney Syndrome, Anhidrosis, and Gastric Bypass.
University Of Iowa Stead Family Children's Hospital
Michael Shy is a Neurologist practicing medicine in Iowa City, Iowa. Dr. Shy is rated as an Elite provider by MediFind in the treatment of Hereditary Sensory Neuropathy Type 1 (HSN1). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Charcot-Marie-Tooth Disease, Hereditary Sensory Neuropathy Type 1 (HSN1), Sensorimotor Polyneuropathy, and Tomaculous Neuropathy. Dr. Shy is currently accepting new patients.
University Of Colorado Hospital Authority
Vera Fridman is a Neurologist practicing medicine in Aurora, Colorado. Dr. Fridman is rated as an Elite provider by MediFind in the treatment of Hereditary Sensory Neuropathy Type 1 (HSN1). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Hereditary Sensory Neuropathy Type 1 (HSN1), Charcot-Marie-Tooth Disease, Hereditary Sensory and Autonomic Neuropathy Type 2, and Hajdu-Cheney Syndrome. Dr. Fridman is currently accepting new patients.
Summary: The Coordination of Rare Diseases at Sanford (CoRDS) is an international patient registry that serves as a centralized resource for rare disease research. Individuals affected by rare diseases, undiagnosed conditions, and disorders of unknown prevalence may voluntarily contribute health information to support natural history studies, participant recruitment, and other research efforts. Through par...
Summary: This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to: * Find the recommended dose of ART0380 that can be given safely to participants alone and in combination with gemcitabine or irinotecan * Learn more about the side effects of ART0380 alone and in combination with gemcitabine or irinotecan * Learn mo...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center